$KNSA Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Kiniksa Pharmaceuticals, Ltd..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Kiniksa Pharmaceuticals, Ltd.. Get notifications about new insider transactions in Kiniksa Pharmaceuticals, Ltd. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 28 2021 | KNSA | Kiniksa Pharmaceut ... | Ragosa Mark | CFO | Option Exercise | A | 0.00 | 3,962 | 0 | 3,962 | |
Apr 28 2021 | KNSA | Kiniksa Pharmaceut ... | Ragosa Mark | CFO | Option Exercise | A | 16.90 | 23,725 | 400,953 | 23,725 | |
Mar 23 2021 | KNSA | Kiniksa Pharmaceut ... | Ragosa Mark | CFO | Option Exercise | A | 0.00 | 2,158 | 0 | 2,158 | |
Mar 23 2021 | KNSA | Kiniksa Pharmaceut ... | Ragosa Mark | CFO | Option Exercise | A | 0.00 | 3,019 | 0 | 3,019 | |
Mar 23 2021 | KNSA | Kiniksa Pharmaceut ... | Paolini John F. | SVP & Chief Medical ... | Option Exercise | A | 0.00 | 3,671 | 0 | 3,671 | |
Mar 23 2021 | KNSA | Kiniksa Pharmaceut ... | Paolini John F. | SVP & Chief Medical ... | Option Exercise | A | 0.00 | 5,676 | 0 | 5,676 | |
Mar 23 2021 | KNSA | Kiniksa Pharmaceut ... | Megna Michael R | Chief Accounting Of ... | Option Exercise | A | 0.00 | 2,163 | 0 | 2,163 | |
Mar 23 2021 | KNSA | Kiniksa Pharmaceut ... | Megna Michael R | Chief Accounting Of ... | Option Exercise | A | 0.00 | 3,231 | 0 | 3,231 | |
Mar 23 2021 | KNSA | Kiniksa Pharmaceut ... | Patel Sanj K | Chairman & CEO | Option Exercise | A | 0.00 | 12,002 | 0 | 12,002 | |
Mar 23 2021 | KNSA | Kiniksa Pharmaceut ... | Patel Sanj K | Chairman & CEO | Option Exercise | A | 0.00 | 18,555 | 0 | 18,555 | |
Mar 23 2021 | KNSA | Kiniksa Pharmaceut ... | Beetham Thomas W. | EVP & Chief Legal O ... | Option Exercise | A | 0.00 | 4,287 | 0 | 4,287 | |
Mar 23 2021 | KNSA | Kiniksa Pharmaceut ... | Beetham Thomas W. | EVP & Chief Legal O ... | Option Exercise | A | 0.00 | 5,855 | 0 | 5,855 | |
Mar 18 2021 | KNSA | Kiniksa Pharmaceut ... | Ragosa Mark | CFO | Option Exercise | A | 0.00 | 3,488 | 0 | 3,488 | |
Mar 18 2021 | KNSA | Kiniksa Pharmaceut ... | Ragosa Mark | CFO | Option Exercise | A | 22.89 | 20,925 | 478,973 | 20,925 | |
Mar 18 2021 | KNSA | Kiniksa Pharmaceut ... | Megna Michael R | Chief Accounting Of ... | Option Exercise | A | 0.00 | 3,098 | 0 | 3,098 | |
Mar 18 2021 | KNSA | Kiniksa Pharmaceut ... | Megna Michael R | Chief Accounting Of ... | Option Exercise | A | 22.89 | 6,195 | 141,804 | 6,195 | |
Mar 18 2021 | KNSA | Kiniksa Pharmaceut ... | Paolini John F. | SVP & Chief Medical ... | Option Exercise | A | 0.00 | 6,900 | 0 | 6,900 | |
Mar 18 2021 | KNSA | Kiniksa Pharmaceut ... | Paolini John F. | SVP & Chief Medical ... | Option Exercise | A | 22.89 | 41,400 | 947,646 | 41,400 | |
Mar 18 2021 | KNSA | Kiniksa Pharmaceut ... | Patel Sanj K | Chairman & CEO | Option Exercise | A | 0.00 | 26,276 | 0 | 26,276 | |
Mar 18 2021 | KNSA | Kiniksa Pharmaceut ... | Patel Sanj K | Chairman & CEO | Option Exercise | A | 22.89 | 157,658 | 3,608,792 | 157,658 | |
Mar 18 2021 | KNSA | Kiniksa Pharmaceut ... | Beetham Thomas W. | EVP & Chief Legal O ... | Option Exercise | A | 0.00 | 8,769 | 0 | 8,769 | |
Mar 18 2021 | KNSA | Kiniksa Pharmaceut ... | Beetham Thomas W. | EVP & Chief Legal O ... | Option Exercise | A | 22.89 | 52,611 | 1,204,266 | 52,611 | |
Feb 10 2021 | KNSA | Kiniksa Pharmaceut ... | Patel Sanj K | Chairman & CEO | Option Exercise | M | 1.59 | 1,600 | 2,544 | 325,271 | |
Feb 10 2021 | KNSA | Kiniksa Pharmaceut ... | Patel Sanj K | Chairman & CEO | Option Exercise | M | 1.59 | 20,401 | 32,438 | 326,871 | |
Feb 10 2021 | KNSA | Kiniksa Pharmaceut ... | Patel Sanj K | Chairman & CEO | Option Exercise | M | 1.59 | 4,924 | 7,829 | 347,272 | |
Feb 10 2021 | KNSA | Kiniksa Pharmaceut ... | Patel Sanj K | Chairman & CEO | Sell | S | 23.07 | 1,137 | 26,231 | 83,336 | 84.5 K to 83.3 K (-1.35 %) |
Feb 10 2021 | KNSA | Kiniksa Pharmaceut ... | Patel Sanj K | Chairman & CEO | Sell | S | 23.06 | 1,600 | 36,896 | 0 | 1.6 K to 0 (-100.00 %) |
Feb 10 2021 | KNSA | Kiniksa Pharmaceut ... | Patel Sanj K | Chairman & CEO | Buy | M | 1.59 | 1,600 | 2,544 | 1,600 | 0 to 1.6 K |
Feb 10 2021 | KNSA | Kiniksa Pharmaceut ... | Patel Sanj K | Chairman & CEO | Sell | S | 23.08 | 23,569 | 543,973 | 84,473 | 108 K to 84.5 K (-21.81 %) |
Feb 10 2021 | KNSA | Kiniksa Pharmaceut ... | Patel Sanj K | Chairman & CEO | Sell | S | 23.00 | 4,528 | 104,144 | 108,042 | 112.6 K to 108 K (-4.02 %) |
Feb 10 2021 | KNSA | Kiniksa Pharmaceut ... | Patel Sanj K | Chairman & CEO | Sell | S | 23.04 | 20,401 | 470,039 | 0 | 20.4 K to 0 (-100.00 %) |
Feb 10 2021 | KNSA | Kiniksa Pharmaceut ... | Patel Sanj K | Chairman & CEO | Buy | M | 1.59 | 20,401 | 32,438 | 20,401 | 0 to 20.4 K |
Feb 10 2021 | KNSA | Kiniksa Pharmaceut ... | Patel Sanj K | Chairman & CEO | Sell | S | 23.00 | 4,924 | 113,252 | 0 | 4.9 K to 0 (-100.00 %) |
Feb 10 2021 | KNSA | Kiniksa Pharmaceut ... | Patel Sanj K | Chairman & CEO | Buy | M | 1.59 | 4,924 | 7,829 | 4,924 | 0 to 4.9 K |
Feb 05 2021 | KNSA | Kiniksa Pharmaceut ... | Beetham Thomas W. | EVP & Chief Legal O ... | Option Exercise | C | 0.00 | 300,000 | 0 | 114,157 | |
Feb 05 2021 | KNSA | Kiniksa Pharmaceut ... | Beetham Thomas W. | EVP & Chief Legal O ... | Sell | S | 22.09 | 2,477 | 54,717 | 297,523 | 300 K to 297.5 K (-0.83 %) |
Feb 05 2021 | KNSA | Kiniksa Pharmaceut ... | Beetham Thomas W. | EVP & Chief Legal O ... | Buy | C | 0.00 | 300,000 | 0 | 300,000 | 0 to 300 K |
Jan 05 2021 | KNSA | Kiniksa Pharmaceut ... | Ragosa Mark | Interim CFO | Option Exercise | M | 0.00 | 4,404 | 0 | 0 | |
Jan 05 2021 | KNSA | Kiniksa Pharmaceut ... | Ragosa Mark | Interim CFO | Payment of Exercise | F | 17.67 | 1,297 | 22,918 | 3,107 | 4.4 K to 3.1 K (-29.45 %) |
Jan 05 2021 | KNSA | Kiniksa Pharmaceut ... | Ragosa Mark | Interim CFO | Buy | M | 0.00 | 4,404 | 0 | 4,404 | 0 to 4.4 K |
Jan 05 2021 | KNSA | Kiniksa Pharmaceut ... | Rizvi Qasim | Chief Commercial Of ... | Option Exercise | M | 0.00 | 7,337 | 0 | 0 | |
Jan 05 2021 | KNSA | Kiniksa Pharmaceut ... | Rizvi Qasim | Chief Commercial Of ... | Payment of Exercise | F | 17.67 | 2,161 | 38,185 | 5,176 | 7.3 K to 5.2 K (-29.45 %) |
Jan 05 2021 | KNSA | Kiniksa Pharmaceut ... | Rizvi Qasim | Chief Commercial Of ... | Buy | M | 0.00 | 7,337 | 0 | 7,337 | 0 to 7.3 K |
Oct 14 2020 | KNSA | Kiniksa Pharmaceut ... | Patel Sanj K | Chairman & CEO | Option Exercise | M | 1.59 | 150,700 | 239,613 | 352,196 | |
Oct 14 2020 | KNSA | Kiniksa Pharmaceut ... | Patel Sanj K | Chairman & CEO | Option Exercise | M | 1.59 | 872 | 1,386 | 502,896 | |
Oct 14 2020 | KNSA | Kiniksa Pharmaceut ... | Patel Sanj K | Chairman & CEO | Sell | S | 21.02 | 99,330 | 2,087,917 | 112,570 | 211.9 K to 112.6 K (-46.88 %) |
Oct 14 2020 | KNSA | Kiniksa Pharmaceut ... | Patel Sanj K | Chairman & CEO | Sell | S | 21.02 | 150,700 | 3,167,714 | 0 | 150.7 K to 0 (-100.00 %) |
Oct 14 2020 | KNSA | Kiniksa Pharmaceut ... | Patel Sanj K | Chairman & CEO | Buy | M | 1.59 | 150,700 | 239,613 | 150,700 | 0 to 150.7 K |
Oct 14 2020 | KNSA | Kiniksa Pharmaceut ... | Patel Sanj K | Chairman & CEO | Sell | S | 21.00 | 670 | 14,070 | 211,900 | 212.6 K to 211.9 K (-0.32 %) |
Oct 14 2020 | KNSA | Kiniksa Pharmaceut ... | Patel Sanj K | Chairman & CEO | Sell | S | 21.00 | 872 | 18,312 | 0 | 872 to 0 (-100.00 %) |
Oct 14 2020 | KNSA | Kiniksa Pharmaceut ... | Patel Sanj K | Chairman & CEO | Buy | M | 1.59 | 872 | 1,386 | 872 | 0 to 872 |
Sep 14 2020 | KNSA | Kiniksa Pharmaceut ... | Patel Sanj K | Chairman & CEO | Option Exercise | A | 15.50 | 180,000 | 2,790,000 | 180,000 | |
Sep 14 2020 | KNSA | Kiniksa Pharmaceut ... | Beetham Thomas W. | EVP & Chief Legal O ... | Option Exercise | A | 15.50 | 75,000 | 1,162,500 | 75,000 | |
Sep 14 2020 | KNSA | Kiniksa Pharmaceut ... | Paolini John F. | SVP & Chief Medical ... | Option Exercise | A | 15.50 | 50,000 | 775,000 | 50,000 | |
Sep 14 2020 | KNSA | Kiniksa Pharmaceut ... | Rizvi Qasim | Chief Commercial Of ... | Option Exercise | A | 15.50 | 75,000 | 1,162,500 | 75,000 | |
Sep 14 2020 | KNSA | Kiniksa Pharmaceut ... | Megna Michael R | Chief Accounting Of ... | Option Exercise | A | 15.50 | 19,000 | 294,500 | 19,000 | |
Jul 29 2020 | KNSA | Kiniksa Pharmaceut ... | Cole G Bradley | Director | Option Exercise | A | 20.09 | 37,965 | 762,717 | 37,965 | |
Jul 28 2020 | KNSA | Kiniksa Pharmaceut ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | A | 0.00 | 1,335,362 | 0 | 11,638,314 | |
Jul 28 2020 | KNSA | Kiniksa Pharmaceut ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | A | 0.00 | 93,210 | 0 | 1,143,650 | |
Jul 02 2020 | KNSA | Kiniksa Pharmaceut ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | A | 25.48 | 37,520 | 956,010 | 37,520 | |
Jul 02 2020 | KNSA | Kiniksa Pharmaceut ... | Levy Richard S | Director | Option Exercise | A | 25.48 | 18,760 | 478,005 | 18,760 | |
Jul 02 2020 | KNSA | Kiniksa Pharmaceut ... | Beetham Thomas W. | EVP & Chief Legal O ... | Sell | S | 25.84 | 2,855 | 73,773 | 0 | 2.9 K to 0 (-100.00 %) |
Jul 02 2020 | KNSA | Kiniksa Pharmaceut ... | Beetham Thomas W. | EVP & Chief Legal O ... | Sell | S | 25.32 | 26,734 | 676,905 | 2,855 | 29.6 K to 2.9 K (-90.35 %) |
Jul 02 2020 | KNSA | Kiniksa Pharmaceut ... | Quart Barry D | Director | Option Exercise | A | 25.48 | 18,760 | 478,005 | 18,760 | |
Jul 02 2020 | KNSA | Kiniksa Pharmaceut ... | Malley Thomas | Director | Option Exercise | A | 25.48 | 18,760 | 478,005 | 18,760 | |
Jul 02 2020 | KNSA | Kiniksa Pharmaceut ... | Popovits Kimberly J | Director | Option Exercise | A | 25.48 | 18,760 | 478,005 | 18,760 | |
Jun 12 2020 | KNSA | Kiniksa Pharmaceut ... | Beetham Thomas W. | EVP & Chief Legal O ... | Option Exercise | M | 1.59 | 13,752 | 21,866 | 112,189 | |
Jun 12 2020 | KNSA | Kiniksa Pharmaceut ... | Beetham Thomas W. | EVP & Chief Legal O ... | Sell | S | 25.07 | 13,752 | 344,763 | 29,589 | 43.3 K to 29.6 K (-31.73 %) |
Jun 12 2020 | KNSA | Kiniksa Pharmaceut ... | Beetham Thomas W. | EVP & Chief Legal O ... | Buy | M | 1.59 | 13,752 | 21,866 | 43,341 | 29.6 K to 43.3 K (+46.48 %) |
May 18 2020 | KNSA | Kiniksa Pharmaceut ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | A | 0.00 | 1,465,603 | 0 | 10,302,952 | |
May 18 2020 | KNSA | Kiniksa Pharmaceut ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | A | 0.00 | 134,397 | 0 | 1,050,440 | |
Apr 22 2020 | KNSA | Kiniksa Pharmaceut ... | Beetham Thomas W. | EVP & Chief Legal O ... | Sell | S | 20.44 | 955 | 19,520 | 29,589 | 30.5 K to 29.6 K (-3.13 %) |
Apr 22 2020 | KNSA | Kiniksa Pharmaceut ... | Beetham Thomas W. | EVP & Chief Legal O ... | Sell | S | 19.56 | 1,563 | 30,572 | 30,544 | 32.1 K to 30.5 K (-4.87 %) |
Apr 22 2020 | KNSA | Kiniksa Pharmaceut ... | Beetham Thomas W. | EVP & Chief Legal O ... | Sell | S | 19.06 | 47,423 | 903,882 | 32,107 | 79.5 K to 32.1 K (-59.63 %) |
Mar 17 2020 | KNSA | Kiniksa Pharmaceut ... | Patel Sanj K | Chairman & CEO | Option Exercise | A | 15.52 | 180,000 | 2,793,600 | 180,000 | |
Mar 17 2020 | KNSA | Kiniksa Pharmaceut ... | Beetham Thomas W. | EVP & Chief Legal O ... | Option Exercise | A | 15.52 | 75,000 | 1,164,000 | 75,000 | |
Mar 17 2020 | KNSA | Kiniksa Pharmaceut ... | Rizvi Qasim | Chief Commercial Of ... | Option Exercise | A | 15.52 | 75,000 | 1,164,000 | 75,000 | |
Mar 17 2020 | KNSA | Kiniksa Pharmaceut ... | Paolini John F. | SVP & Chief Medical ... | Option Exercise | A | 15.52 | 50,000 | 776,000 | 50,000 | |
Mar 17 2020 | KNSA | Kiniksa Pharmaceut ... | Megna Michael R | Chief Accounting Of ... | Option Exercise | A | 15.52 | 17,000 | 263,840 | 17,000 | |
Mar 10 2020 | KNSA | Kiniksa Pharmaceut ... | Patel Sanj K | Chairman & CEO | Sell | S | 20.00 | 33,115 | 662,300 | 212,570 | 245.7 K to 212.6 K (-13.48 %) |
Mar 02 2020 | KNSA | Kiniksa Pharmaceut ... | Paolini John F. | SVP & Chief Medical ... | Option Exercise | M | 1.86 | 12,000 | 22,320 | 197,574 | |
Mar 02 2020 | KNSA | Kiniksa Pharmaceut ... | Paolini John F. | SVP & Chief Medical ... | Buy | M | 1.86 | 12,000 | 22,320 | 30,000 | 18 K to 30 K (+66.67 %) |
Feb 21 2020 | KNSA | Kiniksa Pharmaceut ... | Paolini John F. | SVP & Chief Medical ... | Option Exercise | M | 3.80 | 9,803 | 37,251 | 66,542 | |
Feb 21 2020 | KNSA | Kiniksa Pharmaceut ... | Paolini John F. | SVP & Chief Medical ... | Option Exercise | M | 3.80 | 22,477 | 85,413 | 76,345 | |
Feb 21 2020 | KNSA | Kiniksa Pharmaceut ... | Paolini John F. | SVP & Chief Medical ... | Sell | S | 19.32 | 1,116 | 21,561 | 18,000 | 19.1 K to 18 K (-5.84 %) |
Feb 21 2020 | KNSA | Kiniksa Pharmaceut ... | Paolini John F. | SVP & Chief Medical ... | Sell | S | 18.91 | 8,687 | 164,271 | 19,116 | 27.8 K to 19.1 K (-31.24 %) |
Feb 21 2020 | KNSA | Kiniksa Pharmaceut ... | Paolini John F. | SVP & Chief Medical ... | Buy | M | 3.80 | 9,803 | 37,251 | 27,803 | 18 K to 27.8 K (+54.46 %) |
Feb 21 2020 | KNSA | Kiniksa Pharmaceut ... | Paolini John F. | SVP & Chief Medical ... | Sell | S | 18.27 | 22,477 | 410,655 | 18,000 | 40.5 K to 18 K (-55.53 %) |
Feb 21 2020 | KNSA | Kiniksa Pharmaceut ... | Paolini John F. | SVP & Chief Medical ... | Buy | M | 3.80 | 22,477 | 85,413 | 40,477 | 18 K to 40.5 K (+124.87 %) |
Feb 19 2020 | KNSA | Kiniksa Pharmaceut ... | Beetham Thomas W. | EVP & Chief Legal O ... | Sell | S | 18.58 | 59 | 1,096 | 79,530 | 79.6 K to 79.5 K (-0.07 %) |
Feb 18 2020 | KNSA | Kiniksa Pharmaceut ... | Paolini John F. | SVP & Chief Medical ... | Option Exercise | M | 3.80 | 1,039 | 3,948 | 98,822 | |
Feb 18 2020 | KNSA | Kiniksa Pharmaceut ... | Paolini John F. | SVP & Chief Medical ... | Option Exercise | M | 3.80 | 10,277 | 39,053 | 99,861 | |
Feb 18 2020 | KNSA | Kiniksa Pharmaceut ... | Paolini John F. | SVP & Chief Medical ... | Sell | S | 18.33 | 1,039 | 19,045 | 18,000 | 19 K to 18 K (-5.46 %) |
Feb 18 2020 | KNSA | Kiniksa Pharmaceut ... | Paolini John F. | SVP & Chief Medical ... | Buy | M | 3.80 | 1,039 | 3,948 | 19,039 | 18 K to 19 K (+5.77 %) |
Feb 18 2020 | KNSA | Kiniksa Pharmaceut ... | Paolini John F. | SVP & Chief Medical ... | Sell | S | 18.29 | 10,277 | 187,966 | 18,000 | 28.3 K to 18 K (-36.34 %) |
Feb 18 2020 | KNSA | Kiniksa Pharmaceut ... | Paolini John F. | SVP & Chief Medical ... | Buy | M | 3.80 | 10,277 | 39,053 | 28,277 | 18 K to 28.3 K (+57.09 %) |
Dec 16 2019 | KNSA | Kiniksa Pharmaceut ... | Rizvi Qasim | Chief Commercial Of ... | Option Exercise | A | 0.00 | 7,337 | 0 | 7,337 | |
Dec 16 2019 | KNSA | Kiniksa Pharmaceut ... | Rizvi Qasim | Chief Commercial Of ... | Option Exercise | A | 0.00 | 7,337 | 0 | 7,337 | |
Dec 16 2019 | KNSA | Kiniksa Pharmaceut ... | Rizvi Qasim | Chief Commercial Of ... | Option Exercise | A | 0.00 | 7,337 | 0 | 7,337 | |
Dec 09 2019 | KNSA | Kiniksa Pharmaceut ... | Rizvi Qasim | Chief Commercial Of ... | Option Exercise | A | 10.61 | 30,000 | 318,300 | 30,000 | |
Dec 09 2019 | KNSA | Kiniksa Pharmaceut ... | Paolini John F. | SVP & Chief Medical ... | Option Exercise | M | 1.86 | 8,000 | 14,880 | 209,574 | |
Dec 09 2019 | KNSA | Kiniksa Pharmaceut ... | Paolini John F. | SVP & Chief Medical ... | Buy | M | 1.86 | 8,000 | 14,880 | 8,000 | 0 to 8 K |
Oct 09 2019 | KNSA | Kiniksa Pharmaceut ... | Paolini John F. | SVP & Chief Medical ... | Option Exercise | M | 1.86 | 10,000 | 18,600 | 217,574 | |
Oct 09 2019 | KNSA | Kiniksa Pharmaceut ... | Paolini John F. | SVP & Chief Medical ... | Buy | M | 1.86 | 10,000 | 18,600 | 10,000 | 0 to 10 K |
Sep 19 2019 | KNSA | Kiniksa Pharmaceut ... | Mahoney Stephen F. | President & COO | Option Exercise | A | 8.83 | 82,000 | 724,060 | 82,000 | |
Sep 19 2019 | KNSA | Kiniksa Pharmaceut ... | Beetham Thomas W. | EVP & Chief Legal O ... | Option Exercise | A | 8.83 | 45,000 | 397,350 | 45,000 | |
Sep 19 2019 | KNSA | Kiniksa Pharmaceut ... | Patel Sanj K | Chairman & CEO | Option Exercise | A | 8.83 | 190,000 | 1,677,700 | 190,000 | |
Sep 19 2019 | KNSA | Kiniksa Pharmaceut ... | Heberlig Chris | EVP & CFO | Option Exercise | A | 8.83 | 50,000 | 441,500 | 50,000 | |
Sep 19 2019 | KNSA | Kiniksa Pharmaceut ... | Paolini John F. | SVP & Chief Medical ... | Option Exercise | A | 8.83 | 46,000 | 406,180 | 46,000 | |
Jun 07 2019 | KNSA | Kiniksa Pharmaceut ... | BAKER BROS. ADVISORS LP | Director | Buy | J | 0.00 | 14,840 | 0 | 14,840 | 0 to 14.8 K |
Jun 07 2019 | KNSA | Kiniksa Pharmaceut ... | BAKER BROS. ADVISORS LP | Director | Buy | J | 0.00 | 14,840 | 0 | 14,840 | 0 to 14.8 K |
Jun 07 2019 | KNSA | Kiniksa Pharmaceut ... | BAKER BROS. ADVISORS LP | Director | Sell | J | 0.00 | 200,423 | 0 | 98,980 | 299.4 K to 99 K (-66.94 %) |
May 31 2019 | KNSA | Kiniksa Pharmaceut ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | A | 15.47 | 37,520 | 580,434 | 37,520 | |
May 31 2019 | KNSA | Kiniksa Pharmaceut ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | A | 15.47 | 37,520 | 580,434 | 37,520 | |
May 30 2019 | KNSA | Kiniksa Pharmaceut ... | Quart Barry D | Director | Option Exercise | A | 15.47 | 18,760 | 290,217 | 18,760 | |
May 30 2019 | KNSA | Kiniksa Pharmaceut ... | Malley Thomas | Director | Option Exercise | A | 15.47 | 18,760 | 290,217 | 18,760 | |
May 30 2019 | KNSA | Kiniksa Pharmaceut ... | McCain Tracey L | Director | Option Exercise | A | 15.47 | 18,760 | 290,217 | 18,760 | |
May 30 2019 | KNSA | Kiniksa Pharmaceut ... | Popovits Kimberly J | Director | Option Exercise | A | 15.47 | 18,760 | 290,217 | 18,760 | |
Mar 06 2019 | KNSA | Kiniksa Pharmaceut ... | Heberlig Chris | EVP & CFO | Option Exercise | A | 17.92 | 46,000 | 824,320 | 46,000 | |
Mar 06 2019 | KNSA | Kiniksa Pharmaceut ... | Mahoney Stephen F. | President & COO | Option Exercise | A | 17.92 | 83,000 | 1,487,360 | 83,000 | |
Mar 06 2019 | KNSA | Kiniksa Pharmaceut ... | Paolini John F. | SVP & Chief Medical ... | Option Exercise | A | 17.92 | 51,000 | 913,920 | 51,000 | |
Mar 06 2019 | KNSA | Kiniksa Pharmaceut ... | Patel Sanj K | Chairman & CEO | Option Exercise | A | 17.92 | 187,000 | 3,351,040 | 187,000 | |
Mar 06 2019 | KNSA | Kiniksa Pharmaceut ... | Beetham Thomas W. | EVP & Chief Legal O ... | Option Exercise | A | 17.92 | 42,000 | 752,640 | 42,000 | |
Mar 06 2019 | KNSA | Kiniksa Pharmaceut ... | Levy Richard S | Director | Option Exercise | A | 17.92 | 37,965 | 680,333 | 37,965 | |
Feb 06 2019 | KNSA | Kiniksa Pharmaceut ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | A | 0.00 | 1,818,475 | 0 | 8,837,349 | |
Feb 06 2019 | KNSA | Kiniksa Pharmaceut ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | A | 0.00 | 181,525 | 0 | 916,043 | |
Sep 24 2018 | KNSA | Kiniksa Pharmaceut ... | Patel Sanj K | Chairman & CEO | Option Exercise | A | 30.93 | 125,000 | 3,866,250 | 125,000 | |
Sep 24 2018 | KNSA | Kiniksa Pharmaceut ... | Paolini John F. | SVP & Chief Medical ... | Option Exercise | A | 30.93 | 45,000 | 1,391,850 | 45,000 | |
Sep 24 2018 | KNSA | Kiniksa Pharmaceut ... | Mahoney Stephen F. | President & COO | Option Exercise | A | 30.93 | 50,000 | 1,546,500 | 50,000 | |
Sep 24 2018 | KNSA | Kiniksa Pharmaceut ... | Heberlig Chris | EVP & CFO | Option Exercise | A | 30.93 | 45,000 | 1,391,850 | 45,000 | |
Sep 24 2018 | KNSA | Kiniksa Pharmaceut ... | Beetham Thomas W. | EVP & Chief Legal O ... | Option Exercise | A | 30.93 | 45,000 | 1,391,850 | 45,000 | |
May 31 2018 | KNSA | Kiniksa Pharmaceut ... | Flynn James E | 10% Owner | Option Exercise | C | 0.00 | 383,538 | 0 | 0 | |
May 31 2018 | KNSA | Kiniksa Pharmaceut ... | Flynn James E | 10% Owner | Buy | P | 19.24 | 235,019 | 4,520,943 | 843,352 | 608.3 K to 843.4 K (+38.63 %) |
May 31 2018 | KNSA | Kiniksa Pharmaceut ... | Flynn James E | 10% Owner | Buy | P | 20.91 | 25,000 | 522,748 | 608,333 | 583.3 K to 608.3 K (+4.29 %) |
May 31 2018 | KNSA | Kiniksa Pharmaceut ... | Flynn James E | 10% Owner | Buy | P | 19.81 | 250,000 | 4,953,150 | 583,333 | 333.3 K to 583.3 K (+75.00 %) |
May 31 2018 | KNSA | Kiniksa Pharmaceut ... | Flynn James E | 10% Owner | Buy | P | 18.00 | 333,333 | 5,999,994 | 333,333 | 0 to 333.3 K |
May 31 2018 | KNSA | Kiniksa Pharmaceut ... | Flynn James E | 10% Owner | Buy | C | 0.00 | 383,538 | 0 | 383,538 | 0 to 383.5 K |
May 31 2018 | KNSA | Kiniksa Pharmaceut ... | Cormorant Asset Management, LP | 10% Owner | Option Exercise | C | 0.00 | 830,999 | 0 | 0 | |
May 31 2018 | KNSA | Kiniksa Pharmaceut ... | Cormorant Asset Management, LP | 10% Owner | Buy | P | 18.00 | 69,444 | 1,249,992 | 900,443 | 831 K to 900.4 K (+8.36 %) |
May 31 2018 | KNSA | Kiniksa Pharmaceut ... | Cormorant Asset Management, LP | 10% Owner | Buy | C | 0.00 | 830,999 | 0 | 830,999 | 0 to 831 K |
May 31 2018 | KNSA | Kiniksa Pharmaceut ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | C | 0.00 | 14,658,102 | 0 | 14,658,102 | |
May 31 2018 | KNSA | Kiniksa Pharmaceut ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | C | 0.00 | 14,658,102 | 0 | 0 | |
May 31 2018 | KNSA | Kiniksa Pharmaceut ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | C | 0.00 | 1,399,516 | 0 | 1,399,516 | |
May 31 2018 | KNSA | Kiniksa Pharmaceut ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | C | 0.00 | 1,399,516 | 0 | 0 | |
May 31 2018 | KNSA | Kiniksa Pharmaceut ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | C | 0.00 | 3,284,771 | 0 | 7,018,874 | |
May 31 2018 | KNSA | Kiniksa Pharmaceut ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | C | 0.00 | 3,284,771 | 0 | 0 | |
May 31 2018 | KNSA | Kiniksa Pharmaceut ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | C | 0.00 | 313,621 | 0 | 734,518 | |
May 31 2018 | KNSA | Kiniksa Pharmaceut ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | C | 0.00 | 313,621 | 0 | 0 | |
May 31 2018 | KNSA | Kiniksa Pharmaceut ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | C | 0.00 | 3,734,103 | 0 | 3,734,103 | |
May 31 2018 | KNSA | Kiniksa Pharmaceut ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | C | 0.00 | 3,734,103 | 0 | 0 |